{"id":"https://openalex.org/W2154773963","doi":"https://doi.org/10.1089/104454602762599853","title":"Prevalence and Patterns of Use of Psychoactive Medicines in Individuals with Autism in the Autism Society of North Carolina","display_name":"Prevalence and Patterns of Use of Psychoactive Medicines in Individuals with Autism in the Autism Society of North Carolina","alternate_titles":[],"publication_year":2002,"publication_date":"2002-12-01","ids":{"openalex":"https://openalex.org/W2154773963","doi":"https://doi.org/10.1089/104454602762599853","mag":"2154773963","pmid":"https://pubmed.ncbi.nlm.nih.gov/12625991"},"language":"en","primary_location":{"id":"doi:10.1089/104454602762599853","doi":"https://doi.org/10.1089/104454602762599853","is_oa":false,"landing_page_url":"https://doi.org/10.1089/104454602762599853","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2154773963"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010074116","display_name":"Kristen S. L. Lam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kristen S. Langworthy-Lam","raw_affiliation_strings":["The Nisonger Center for Mental Retardation and Developmental Disabilities, The Ohio State University, Columus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Nisonger Center for Mental Retardation and Developmental Disabilities, The Ohio State University, Columus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110833758","display_name":"Michael G. Aman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael G. Aman","raw_affiliation_strings":["The Nisonger Center for Mental Retardation and Developmental Disabilities, The Ohio State University, Columus, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Nisonger Center for Mental Retardation and Developmental Disabilities, The Ohio State University, Columus, Ohio","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060273030","display_name":"Mary E. Van Bourgondien","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mary E. Van Bourgondien","raw_affiliation_strings":["Division TEACCH, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division TEACCH, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.5912,"has_fulltext":false,"cited_by_count":138,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.88702992,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"12","issue":"4","first_page":"311","last_page":"321"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10106","display_name":"Autism Spectrum Disorder Research","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10106","display_name":"Autism Spectrum Disorder Research","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13393","display_name":"Child Nutrition and Feeding Issues","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/autism-spectrum-disorder","display_name":"autism spectrum disorder","score":0.9919999837875366},{"id":"https://openalex.org/keywords/psychotropic-drugs","display_name":"psychotropic drugs","score":0.6959999799728394},{"id":"https://openalex.org/keywords/drug-use-prevalence","display_name":"drug use prevalence","score":0.5189999938011169},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.8880000114440918},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":1.0},{"id":"https://openalex.org/keywords/stimulants","display_name":"stimulants","score":0.9850000143051147},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9959999918937683},{"id":"https://openalex.org/keywords/over-the-counter-drugs","display_name":"over-the-counter drugs","score":0.746999979019165},{"id":"https://openalex.org/keywords/autism-severity","display_name":"autism severity","score":0.7110000252723694},{"id":"https://openalex.org/keywords/intellectual-disability","display_name":"intellectual disability","score":0.9860000014305115}],"concepts":[{"id":"https://openalex.org/C205778803","wikidata":"https://www.wikidata.org/wiki/Q38404","display_name":"Autism","level":2,"score":0.9518812894821167},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.6249442100524902},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5114259123802185},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4159361720085144},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.38108503818511963},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.354777067899704},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07066395878791809}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001321","descriptor_name":"Autistic Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001321","descriptor_name":"Autistic Disorder","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003625","descriptor_name":"Data Collection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009657","descriptor_name":"North Carolina","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D016015","descriptor_name":"Logistic Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/104454602762599853","doi":"https://doi.org/10.1089/104454602762599853","is_oa":false,"landing_page_url":"https://doi.org/10.1089/104454602762599853","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:12625991","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12625991","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of child and adolescent psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G125609","display_name":null,"funder_award_id":"N01-MH-80011","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G965855566","display_name":"RESEARCH UNITS ON PEDIATRIC PSYCHOPHARMACOLOGY--AUTISM","funder_award_id":"n01mh080011-005","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320309374","display_name":"Ohio State University","ror":"https://ror.org/00rs6vg23"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W200668642","https://openalex.org/W340753846","https://openalex.org/W1574054177","https://openalex.org/W1597485178","https://openalex.org/W1937469117","https://openalex.org/W1968430210","https://openalex.org/W1969784573","https://openalex.org/W1983422553","https://openalex.org/W1986360512","https://openalex.org/W2000624544","https://openalex.org/W2034469737","https://openalex.org/W2040073138","https://openalex.org/W2079773266","https://openalex.org/W2092691320","https://openalex.org/W2099576957","https://openalex.org/W2099578169","https://openalex.org/W2102784811","https://openalex.org/W2147341063","https://openalex.org/W2333611930"],"related_works":["https://openalex.org/W340753846","https://openalex.org/W2056453955","https://openalex.org/W2034469737","https://openalex.org/W2102784811","https://openalex.org/W7042652381","https://openalex.org/W2888011925","https://openalex.org/W2520462646","https://openalex.org/W2067294597","https://openalex.org/W3202136718","https://openalex.org/W2051713615"],"abstract_inverted_index":{"The":[0,56,104],"aim":[1],"of":[2,12,21,30,36,40,46,50,54,120,164],"this":[3],"study":[4],"was":[5,113],"to":[6,79,140],"assess":[7],"the":[8,37,47,51,75,80,121,129,180],"prevalence":[9],"and":[10,14,67,98,125,135,151,154],"patterns":[11],"psychoactive":[13,165],"over-the-counter":[15],"medicines":[16,61],"in":[17],"a":[18,27,175],"large":[19],"cohort":[20],"individuals":[22,86,171],"with":[23,87,144,161,172],"autism.":[24,103],"We":[25],"conducted":[26,139],"mail":[28],"survey":[29,57],"3,228":[31],"families":[32,73],"that":[33,170],"are":[34,174],"members":[35],"Autism":[38,52],"Society":[39,53],"North":[41],"Carolina.":[42],"This":[43],"is":[44,189],"one":[45],"largest":[48],"chapters":[49],"America.":[55],"form":[58],"addressed":[59],"current":[60],"used,":[62],"side":[63],"effects,":[64],"demographic":[65],"characteristics,":[66],"medical":[68],"conditions.":[69],"Some":[70],"1,538":[71],"member":[72],"within":[74],"society":[76],"(48%)":[77],"responded":[78],"survey.":[81],"In":[82],"all,":[83],"703":[84],"(45.7%)":[85],"autism":[88,150,173],"were":[89,128,138,158],"taking":[90,107],"psychotropic":[91],"drugs,":[92],"191":[93],"(12.4%)":[94],"antiepileptic":[95],"drugs":[96],"(AEDs),":[97],"86":[99],"(5.7%)":[100],"supplements":[101],"for":[102,184],"total":[105],"number":[106],"psychotropic,":[108],"antiepileptic,":[109],"or":[110],"vitamin":[111],"treatments":[112],"816":[114],"(53.1%).":[115],"Antidepressants":[116],"(taken":[117],"by":[118],"21.7%":[119],"sample),":[122],"antipsychotics":[123],"(16.8%),":[124],"stimulants":[126],"(13.9%)":[127],"most":[130,185],"commonly":[131],"prescribed":[132],"agents.":[133,166],"Univariate":[134],"multivariate":[136],"analyses":[137],"examine":[141],"factors":[142],"associated":[143,160],"treatment.":[145],"Greater":[146],"age,":[147],"more":[148,155],"severe":[149],"mental":[152],"retardation,":[153],"restricted":[156],"housing":[157],"often":[159],"greater":[162],"use":[163],"These":[167],"findings":[168],"suggest":[169],"frequently":[176],"medicated":[177],"group,":[178],"although":[179],"empirical":[181],"research":[182],"support":[183],"agents":[186],"being":[187],"used":[188],"still":[190],"very":[191],"limited.":[192]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2154773963","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":6},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
